Berlin Translational Dialogue – RNA-Medicine: From RNA Discoveries to Future Therapies

Tuesday, 08 November 2016

On November 8th, 2015, on the eve of the “Falling Walls” conference, the first Berlin Translational Dialogue was hosted by Elsevier and brought together leading international and Berlin-based experts from translation-focused biomedical research institutions to foster an open dialogue among Berlin-based institutions and since Berlin has been identified as an emerging hub in basic and clinical biomedical research, this was an ideal setting to emphasize the relevance of translational medicine. Based on Berlin’s institutional breath and the notable inauguration of the Berlin Institute of Health (BIH), there is significant potential for the city to become a leader in prescription-, personalized-, systems-, functional- or by-design medicine.

Last year’s Berlin Translational Dialogue consisted of a half-day workshop and an interactive panel titled: “Innovate, share, collaborate – How to create environments that deliver next-generation medicine”. Chaired by Stefan Kaufmann (MPI-IB), speakers and panelists included Erwin Böttinger (BIH), Ulrich Dirnagl (Charité), Nikolaus Rajewsky (Berlin Insitute for Medical Systembs Biology, BIMSB), Kenneth Chien (Karolinska Institute), Karl Max Einhäupl (Charité) Michael A. Teitell (UCLA), Michaela Frye (Wellcome Trust-MRC Cambridge Stem Cell Institute) and Thomas Sommer (MDC).

For more information on last year’s Berlin Translational Dialogue please go to Elsevier Connect:


Contact Details